Thomas Geuens is a visionary biochemist and accomplished executive currently serving as Chief Technology Officer and Head of Clinical Manufacturing at simAbs, where they drive the development of groundbreaking bio-manufacturing platforms for therapeutic monoclonal antibodies. With a Ph.D. in Biochemistry and Biotechnology, Thomas has extensive experience in both academic research and industrial innovation. Their previous roles include postdoctoral researcher at Maastricht University's MERLN Institute and contributions to international collaborations in regenerative medicine. Passionate about leading teams and fostering innovation, Thomas is dedicated to advancing biotechnology and delivering life-changing therapeutics to patients worldwide.
This person is not in the org chart
This person is not in any teams
This person is not in any offices